409 related articles for article (PubMed ID: 32592935)
21. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
Hersrud SL; Kovács AD; Pearce DA
Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
[TBL] [Abstract][Full Text] [Related]
22. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
Drack AV; Miller JN; Pearce DA
J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).
Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T
Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148
[TBL] [Abstract][Full Text] [Related]
24. Histopathologic and immunocytochemical analysis of the retina and ocular tissues in Batten disease.
Bensaoula T; Shibuya H; Katz ML; Smith JE; Johnson GS; John SK; Milam AH
Ophthalmology; 2000 Sep; 107(9):1746-53. PubMed ID: 10964839
[TBL] [Abstract][Full Text] [Related]
25. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
[TBL] [Abstract][Full Text] [Related]
26. Autophagy is disrupted in a knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
Cao Y; Espinola JA; Fossale E; Massey AC; Cuervo AM; MacDonald ME; Cotman SL
J Biol Chem; 2006 Jul; 281(29):20483-93. PubMed ID: 16714284
[TBL] [Abstract][Full Text] [Related]
27. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
[TBL] [Abstract][Full Text] [Related]
28. A human model of Batten disease shows role of CLN3 in phagocytosis at the photoreceptor-RPE interface.
Tang C; Han J; Dalvi S; Manian K; Winschel L; Volland S; Soto CA; Galloway CA; Spencer W; Roll M; Milliner C; Bonilha VL; Johnson TB; Latchney L; Weimer JM; Augustine EF; Mink JW; Gullapalli VK; Chung M; Williams DS; Singh R
Commun Biol; 2021 Feb; 4(1):161. PubMed ID: 33547385
[TBL] [Abstract][Full Text] [Related]
29. CLN3 regulates endosomal function by modulating Rab7A-effector interactions.
Yasa S; Modica G; Sauvageau E; Kaleem A; Hermey G; Lefrancois S
J Cell Sci; 2020 Mar; 133(6):. PubMed ID: 32034082
[TBL] [Abstract][Full Text] [Related]
30. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P
Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874
[TBL] [Abstract][Full Text] [Related]
31. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
Ding SL; Tecedor L; Stein CS; Davidson BL
Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
[TBL] [Abstract][Full Text] [Related]
32. Evidence for aberrant astrocyte hemichannel activity in Juvenile Neuronal Ceroid Lipofuscinosis (JNCL).
Burkovetskaya M; Karpuk N; Xiong J; Bosch M; Boska MD; Takeuchi H; Suzumura A; Kielian T
PLoS One; 2014; 9(4):e95023. PubMed ID: 24736558
[TBL] [Abstract][Full Text] [Related]
33. Microglia in juvenile neuronal ceroid lipofuscinosis are primed toward a pro-inflammatory phenotype.
Xiong J; Kielian T
J Neurochem; 2013 Oct; 127(2):245-58. PubMed ID: 23919525
[TBL] [Abstract][Full Text] [Related]
34. Altered gene expression in the eye of a mouse model for batten disease.
Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
[TBL] [Abstract][Full Text] [Related]
35. Developmental impairments of select neurotransmitter systems in brains of Cln3(Deltaex7/8) knock-in mice, an animal model of juvenile neuronal ceroid lipofuscinosis.
Herrmann P; Druckrey-Fiskaaen C; Kouznetsova E; Heinitz K; Bigl M; Cotman SL; Schliebs R
J Neurosci Res; 2008 Jun; 86(8):1857-70. PubMed ID: 18265413
[TBL] [Abstract][Full Text] [Related]
36. Altered flurothyl seizure induction latency, phenotype, and subsequent mortality in a mouse model of juvenile neuronal ceroid lipofuscinosis/batten disease.
Kriscenski-Perry E; Applegate CD; Serour A; Mhyre TR; Leonardo CC; Pearce DA
Epilepsia; 2002 Oct; 43(10):1137-40. PubMed ID: 12366726
[TBL] [Abstract][Full Text] [Related]
37. Deterioration of visual quality and acuity as the first sign of ceroid lipofuscinosis type 3 (CLN3), a rare neurometabolic disease.
Purzycka-Olewiecka JK; Hetmańczyk-Sawicka K; Kmieć T; Szczęśniak D; Trubicka J; Krawczyński M; Pronicki M; Ługowska A
Metab Brain Dis; 2023 Feb; 38(2):709-715. PubMed ID: 36576693
[TBL] [Abstract][Full Text] [Related]
38. A mouse mutant deficient in both neuronal ceroid lipofuscinosis-associated proteins CLN3 and TPP1.
Sleat DE; Banach-Petrosky W; Larrimore KE; Nemtsova Y; Wiseman JA; Najafi A; Johnson D; Poole TA; Takahashi K; Cooper JD; Lobel P
J Inherit Metab Dis; 2023 Jul; 46(4):720-734. PubMed ID: 37078466
[TBL] [Abstract][Full Text] [Related]
39. Cln3(Deltaex7/8) knock-in mice with the common JNCL mutation exhibit progressive neurologic disease that begins before birth.
Cotman SL; Vrbanac V; Lebel LA; Lee RL; Johnson KA; Donahue LR; Teed AM; Antonellis K; Bronson RT; Lerner TJ; MacDonald ME
Hum Mol Genet; 2002 Oct; 11(22):2709-21. PubMed ID: 12374761
[TBL] [Abstract][Full Text] [Related]
40. Novel homozygous CLN3 missense variant in isolated retinal dystrophy: A case report and electron microscopic findings.
Mizobuchi K; Hayashi T; Yoshitake K; Fujinami K; Tachibana T; Tsunoda K; Iwata T; Nakano T
Mol Genet Genomic Med; 2020 Aug; 8(8):e1308. PubMed ID: 32441891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
